Research Topic

Immune Modulation in Tumor Microenvironment: New Perspectives for Cancer Immunotherapy

About this Research Topic

Emerging immunotherapies, such as the immune checkpoint blockade therapy (ICB) and chimeric antigen receptors T-cell (CAR-T) therapy, have achieved promising results in treating certain types of cancer. However, not all cancer patients benefit from these advanced immunotherapeutic approaches because of intrinsic and acquired resistance. Tumors are heterogeneous and structurally complex tissues comprised of various types of cells, including tumor cells, fibroblasts, immune cells, endothelial cells, and extracellular structural and signaling molecules. Together they form tumor microenvironment (TME), in which various mechanisms are initiated by tumor cells, non-tumor cells, extracellular matrix proteins, signal factors, and metabolic molecules to suppress anti-tumor immune response. Intensive investigations have focused on discovering these mechanisms, developing strategies to overcome immunosuppressive TME, and improving the efficiency of immunotherapies.

 

This Research Topic focuses on the immunosuppressive TME in tumor initiation, progression, and resistance to immunotherapies. We aim to publish a collection of outstanding studies on (1) TME-based immune escape mechanisms; (2) key immune modulators in TME and their regulated signaling/pathways; and (3) strategies and approaches to alter immunosuppressive TME in favor of response to immunotherapies. 

 

We welcome contributions in the form of Original Research Articles, Reviews, and Mini-Reviews that cover but are not limited to the following topics related to immune modulators in TME:

- Modulation of immune TME by tumor-intrinsic signals

- Immunoregulatory cells in TME and their immunostimulatory and immunosuppressive mechanisms

- Chronic infection, inflammation, and cancer progression

- Extracellular factors secreted by tumor and non-tumor cells that regulate the activation and exhaustion of tumor-infiltrating immune cells

- Chemokine/cytokines-introduced immunosuppression in TME

- Landscape of immune TME via data integration and bioinformatic analysis

- Strategies of targeting immune modulator/immune cell for cancer therapies


Methods describing new technological approaches to study immune modulation in tumor microenvironment are also welcome.


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserve the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.


Keywords: Tumor microenvironment, Immune therapy, Immune suppression, Inflammation, Chronic infection, Cancer progression


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Emerging immunotherapies, such as the immune checkpoint blockade therapy (ICB) and chimeric antigen receptors T-cell (CAR-T) therapy, have achieved promising results in treating certain types of cancer. However, not all cancer patients benefit from these advanced immunotherapeutic approaches because of intrinsic and acquired resistance. Tumors are heterogeneous and structurally complex tissues comprised of various types of cells, including tumor cells, fibroblasts, immune cells, endothelial cells, and extracellular structural and signaling molecules. Together they form tumor microenvironment (TME), in which various mechanisms are initiated by tumor cells, non-tumor cells, extracellular matrix proteins, signal factors, and metabolic molecules to suppress anti-tumor immune response. Intensive investigations have focused on discovering these mechanisms, developing strategies to overcome immunosuppressive TME, and improving the efficiency of immunotherapies.

 

This Research Topic focuses on the immunosuppressive TME in tumor initiation, progression, and resistance to immunotherapies. We aim to publish a collection of outstanding studies on (1) TME-based immune escape mechanisms; (2) key immune modulators in TME and their regulated signaling/pathways; and (3) strategies and approaches to alter immunosuppressive TME in favor of response to immunotherapies. 

 

We welcome contributions in the form of Original Research Articles, Reviews, and Mini-Reviews that cover but are not limited to the following topics related to immune modulators in TME:

- Modulation of immune TME by tumor-intrinsic signals

- Immunoregulatory cells in TME and their immunostimulatory and immunosuppressive mechanisms

- Chronic infection, inflammation, and cancer progression

- Extracellular factors secreted by tumor and non-tumor cells that regulate the activation and exhaustion of tumor-infiltrating immune cells

- Chemokine/cytokines-introduced immunosuppression in TME

- Landscape of immune TME via data integration and bioinformatic analysis

- Strategies of targeting immune modulator/immune cell for cancer therapies


Methods describing new technological approaches to study immune modulation in tumor microenvironment are also welcome.


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserve the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.


Keywords: Tumor microenvironment, Immune therapy, Immune suppression, Inflammation, Chronic infection, Cancer progression


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

08 June 2021 Abstract
06 October 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

08 June 2021 Abstract
06 October 2021 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..